Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial.
Vanni T, Thomé BC, Sparrow E, Friede M, Fox CB, Beckmann AM, Huynh C, Mondini G, Silveira DH, Viscondi JYK, Braga PE, Silva AD, Salomão MDG, Piorelli RO, Santos JP, Gattás VL, Lucchesi MBB, Oliveira MMM, Koike ME, Kallas EG, Campos LMA, Coelho EB, Siqueira MAM, Garcia CC, Miranda MD, Paiva TM, Timenetsky MDCST, Adami EA, Akamatsu MA, Ho PL, Precioso AR. Vanni T, et al. Among authors: garcia cc. PLoS One. 2022 Oct 18;17(10):e0274943. doi: 10.1371/journal.pone.0274943. eCollection 2022. PLoS One. 2022. PMID: 36256646 Free PMC article. Clinical Trial.
Influenza A/Singapore (H3N2) component vaccine in systemic lupus erythematosus: A distinct pattern of immunogenicity.
Claudino Formiga FF, Silva CA, Pedrosa TDN, Aikawa NE, Pasoto SG, Garcia CC, Capão ASV, Martins VAO, Proença ACT, Fuller R, Yuki EFN, Vendramini MBG, Rosário DCD, Brandão LMKR, Sartori AMC, Antonangelo L, Bonfá E, Borba EF. Claudino Formiga FF, et al. Among authors: garcia cc. Lupus. 2021 Oct;30(12):1915-1922. doi: 10.1177/09612033211040371. Epub 2021 Aug 28. Lupus. 2021. PMID: 34459317
Low prevalence of influenza A strains with resistance markers in Brazil during 2017-2019 seasons.
Sousa TDC, Martins JSCC, Miranda MD, Garcia CC, Resende PC, Santos CA, Debur MDC, Rodrigues RR, Cavalcanti AC, Gregianini TS, Iani FCM, Pereira FM, Fernandes SB, Ferreira JA, Santos KCO, Motta F, Brown D, de Almeida WAF, Siqueira MM, Matos ADR. Sousa TDC, et al. Among authors: garcia cc. Front Public Health. 2022 Sep 14;10:944277. doi: 10.3389/fpubh.2022.944277. eCollection 2022. Front Public Health. 2022. PMID: 36187691 Free PMC article.
Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile.
Matos AR, Resende PC, Miranda MD, Garcia CC, Caetano BC, Lopes JCO, Debur MC, Cury ALF, Vianna LA, Lima MC, Schirmer M, Gubareva L, Hurt AC, Brown DW, Siqueira MM. Matos AR, et al. Among authors: garcia cc. Antiviral Res. 2018 Jun;154:35-43. doi: 10.1016/j.antiviral.2018.03.010. Epub 2018 Mar 28. Antiviral Res. 2018. PMID: 29601892
Identification of SARS-CoV-2 and additional respiratory pathogens cases under the investigation of COVID-19 initial phase in a Brazilian reference laboratory.
Matos ADR, Motta FC, Caetano BC, Ogrzewalska M, Garcia CC, Lopes JCO, Miranda M, Livorati MTFP, Abreu A, Brown D, Siqueira MM. Matos ADR, et al. Among authors: garcia cc. Mem Inst Oswaldo Cruz. 2020 Sep 18;115:e200232. doi: 10.1590/0074-02760200232. eCollection 2020. Mem Inst Oswaldo Cruz. 2020. PMID: 32965332 Free PMC article.
Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells.
Barreto-Vieira DF, da Silva MAN, Garcia CC, Miranda MD, Matos ADR, Caetano BC, Resende PC, Motta FC, Siqueira MM, Girard-Dias W, Archanjo BS, Barth OM. Barreto-Vieira DF, et al. Among authors: garcia cc. Mem Inst Oswaldo Cruz. 2021 Feb 8;116:e200443. doi: 10.1590/0074-02760200443. eCollection 2021. Mem Inst Oswaldo Cruz. 2021. PMID: 33566951 Free PMC article.
Protective immunity and safety of a genetically modified influenza virus vaccine.
Barbosa RP, Salgado AP, Garcia CC, Filho BG, Gonçalves AP, Lima BH, Lopes GA, Rachid MA, Peixoto AC, de Oliveira DB, Ataíde MA, Zirke CA, Cotrim TM, Costa ÉA, Almeida GM, Russo RC, Gazzinelli RT, Machado Ade M. Barbosa RP, et al. Among authors: garcia cc. PLoS One. 2014 Jun 13;9(6):e98685. doi: 10.1371/journal.pone.0098685. eCollection 2014. PLoS One. 2014. PMID: 24927156 Free PMC article.
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project.
Valim V, Martins-Filho OA, Gouvea MDPG, Camacho LAB, Villela DAM, de Lima SMB, Azevedo AS, Neto LFP, Domingues CMAS, de Medeiros Junior NF, Moulaz IR, Dias LH, Miyamoto ST, Teixeira-Carvalho A, Mill JG; Half Dose ChAdOx Study Group. Valim V, et al. Front Immunol. 2022 Aug 29;13:966416. doi: 10.3389/fimmu.2022.966416. eCollection 2022. Front Immunol. 2022. PMID: 36105814 Free PMC article. Clinical Trial.
254 results